Oxatomide

DB12877ApprovedSmall molecule

Oxatomide is an antihistamine indicated in the treatment and prevention of allergic symptoms. Oxatomide has been used in trials studying the treatment of Muscular Dystrophy, Duchenne.

Chemical structure of Oxatomide
Mechanism
Curator reviewed
Formula / weight
C27H30N4O · 426.564 g/mol (avg)
Code names
KW-4354 · McN-JR 35443 · R 35 443

Resolves to

Compound
UNIIJ31IL9Z2EECAS60607-34-3ChEMBLCHEMBL13828ChEBI31943PubChem4615KEGGD01773
Clinical / RWD
RxNorm54236ATCR06AE06PharmGKBPA163522137
Structure
InChIKeyBAINIUMDFURPJM-UHFFFAOYSA-NSMILESO=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Targets
P35367HRH1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
422Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
5ContraindicationsEach with its own population and attribute set
Sign in
7Marketed productsAcross 3 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Oxatomide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In